MRI ‐based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy
ANZ Journal of Surgery · 2024
DOI: 10.1111/ans.18876 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2024. Verfasst von Yangyang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Shandong First Medical University, Tai'an, People's Republic of China. Hauptthemen laut MEDLINE: Rectal Neoplasms, Lymphatic Metastasis, Neoadjuvant Therapy, Magnetic Resonance Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Fujian Provincial Health Technology Project, Medical Science Research Foundation of Beijing Medical and Health Foundation, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Backgrounds The aim of this study was to assess the significant risk factors that predict lymph node metastasis in ypT0 patients with locally advanced rectal cancer following chemoradiotherapy (CRT). Additionally, the study aimed to identify high‐risk groups who would not be suitable candidates for a rectal‐preserving strategy, despite achieving a complete tumour response.
Methods
Between 2013 and 2021, 226 ypT0 patients with stages II/III rectal cancer underwent CRT and radical surgery were enrolled. Two groups of patients were evaluated: those with lymph nodes metastasis and those without. The selection of variables for multivariable logistic regression was conducted through bivariate logistic regression analysis. Furthermore, the determination of optimal cutoff values for risk factors was achieved using ROC curve analysis.
Results
Nearly 8% (18/226) of patients with ypT0 had positive lymph nodes (LN) on final pathology. Four variables resulted as being independent factors of LN metastasis: pre‐CRT tumour movability (OR = 8.618, P = 0.003), pre‐CRT maximal LN size (OR = 28.474, P = 0.004), post‐CRT tumour vertical length (OR = 1.492, P = 0.050), post‐CRT anaemia (OR = 10.288, P = 0.001). The optimal cutoff point of pre‐CRT maximal LN size and post‐CRT tumour vertical length was 7.50 mm and 3.05 cm, respectively.
Conclusion
The prevalence of lymph node metastasis remains at 8% among patients who achieve pathological complete regression of the primary tumour. In instances where patients are considered appropriate candidates for a rectal‐preserving strategy after clinical complete remission, careful consideration should be given to the selection of this strategy if specific risk factors are present. These risk factors encompass a maximal LN size surpassing 7.50 mm prior to CRT, a fixed tumour prior to CRT, a tumour vertical length exceeding 3.05 cm after CRT, and the existence of anaemia subsequent to CRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, the Second Affiliated Hospital of Shandong First Medical University, Tai'an, People's Republic of China.
- Department of Colorectal Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.
- Follow-Up Center, Union Hospital, Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.
ORCID-Profile: Yangyang Wang
Förderung
- Fujian Provincial Health Technology Project
- Medical Science Research Foundation of Beijing Medical and Health Foundation
- Natural Science Foundation of Fujian Province
- Tai'an Science and Technology Development Plan Foundation of Shandong Province
- Joint Funds for the innovation of Science and Technology, Fujian province
- Bethune Charitable Foundation
Zitieren
APA
Wang, Y., Wang, X., Huang, S., Chen, J., & Huang, Y. (2024). MRI ‐based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy. ANZ Journal of Surgery. https://doi.org/10.1111/ans.18876
Vancouver
Wang Y, Wang X, Huang S, Chen J, Huang Y. MRI ‐based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy. ANZ Journal of Surgery. 2024. doi:10.1111/ans.18876
BibTeX
@article{Wang2024,
author = {Wang, Yangyang and Wang, Xiaojie and Huang, Shenghui and Chen, Jinhua and Huang, Ying},
title = {MRI ‐based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy},
journal = {ANZ Journal of Surgery},
year = {2024},
doi = {10.1111/ans.18876}
}
EUVIMED